Clinical Trials Directory

Trials / Completed

CompletedNCT03357393

Patient-controlled Sedation With Propofol Versus Combined Sedation During Bronchoscopy

Patient-controlled Sedation With Propofol Versus Combined Sedation During Bronchoscopy - a Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
150 (actual)
Sponsor
Lena Nilsson · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

bronchoscopy - a randomized controlled trial" (EudraCT number: 2015-005274-38, protocol number: "BRONSE") is a phase IV single centre prospective randomized controlled trial with parallel groups. A total of 150 adult outpatients undergo diagnostic bronchoscopy during sedation and are randomized into three sedation arms (1:1:1); sedation with midazolam and morphine-scopolamine as premedication (clinical routine), sedation with propofol using PCS and morphine-scopolamine as premedication, and sedation with propofol using PCS and glycopyrronium bromide as premedication. The study is partially blinded, the bronchoscopist is blinded regarding given premedication for patients given PCS (two sedation arms). The hypothesis is that PCS increase the amount of patients ready for discharge, and further that patient characteristics affect the amount of propofol administered. The endpoints are primarily the amount of patients ready for discharge within 2 hours and secondary assessment of patient recovery and satisfaction as well as bronchoscopist evaluation and doses of administrated drugs. Finally safety variables are collected such as vital signs and interventions performed to maintain cardiovascular and respiratory stability.

Conditions

Interventions

TypeNameDescription
DRUGMidazolamMidazolam is givenas sedation to the Control arm.
DRUGPropofol-LipuroPropofol is given as sedation to both intervention arms.
DRUGmorphine-scopolamineGiven as premedication for the Control arm and one of the interventions arms.
DRUGGlycopyrrolateGiven as premedication for one of the intervention arms..

Timeline

Start date
2016-04-04
Primary completion
2017-05-09
Completion
2017-05-09
First posted
2017-11-29
Last updated
2021-01-05
Results posted
2021-01-05

Source: ClinicalTrials.gov record NCT03357393. Inclusion in this directory is not an endorsement.